Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Folate receptor ╬▒ associated with triple-negative breast cancer and poor prognosis.

Zhang Z, Wang J, Tacha DE, Li P, Bremer RE, Chen H, Wei B, Xiao X, Da J, Skinner K, Hicks DG, Bu H, Tang P.

Arch Pathol Lab Med. 2014 Jul;138(7):890-5. doi: 10.5858/arpa.2013-0309-OA. Epub 2013 Sep 13.

PMID:
24028341
[PubMed - in process]
2.

Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease.

O'Shannessy DJ, Somers EB, Maltzman J, Smale R, Fu YS.

Springerplus. 2012 Sep 28;1:22. doi: 10.1186/2193-1801-1-22. eCollection 2012.

PMID:
23961352
[PubMed]
Free PMC Article
4.

Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.

Azizun-Nisa, Bhurgri Y, Raza F, Kayani N.

Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):553-6.

PMID:
19256737
[PubMed - indexed for MEDLINE]
Free Article
5.

Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component.

Brower ST, Ahmed S, Tartter PI, Bleiweiss I, Amberson JB.

Ann Surg Oncol. 1995 Sep;2(5):440-4.

PMID:
7496840
[PubMed - indexed for MEDLINE]
6.

Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases.

Wang-Rodriguez J, Cross K, Gallagher S, Djahanban M, Armstrong JM, Wiedner N, Shapiro DH.

Mod Pathol. 2002 Aug;15(8):853-61.

PMID:
12181271
[PubMed - indexed for MEDLINE]
Free Article
7.

Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers.

Koo HR, Cho N, Song IC, Kim H, Chang JM, Yi A, Yun BL, Moon WK.

J Magn Reson Imaging. 2012 Jul;36(1):145-51. doi: 10.1002/jmri.23635. Epub 2012 Mar 5.

PMID:
22392859
[PubMed - indexed for MEDLINE]
8.

Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.

Ferguson NL, Bell J, Heidel R, Lee S, Vanmeter S, Duncan L, Munsey B, Panella T, Orucevic A.

Breast J. 2013 Jan-Feb;19(1):22-30. doi: 10.1111/tbj.12059. Epub 2012 Dec 13.

PMID:
23240985
[PubMed - indexed for MEDLINE]
9.

Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer.

Chen XS, Ma CD, Wu JY, Yang WT, Lu HF, Wu J, Lu JS, Shao ZM, Shen ZZ, Shen KW.

Tumori. 2010 Jan-Feb;96(1):103-10.

PMID:
20437866
[PubMed - indexed for MEDLINE]
10.

Age related influence of triple receptor status on metastatic breast cancer post relapse survival.

Todorovic-Rakovic N, Neskovic-Konstantinovic Z.

J BUON. 2013 Oct-Dec;18(4):851-8.

PMID:
24344008
[PubMed - indexed for MEDLINE]
11.

MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.

Lowery AJ, Miller N, Devaney A, McNeill RE, Davoren PA, Lemetre C, Benes V, Schmidt S, Blake J, Ball G, Kerin MJ.

Breast Cancer Res. 2009;11(3):R27. doi: 10.1186/bcr2257. Epub 2009 May 11.

PMID:
19432961
[PubMed - indexed for MEDLINE]
Free PMC Article
12.
13.

Outcome evaluation in pre-trastuzumab era between different breast cancer phenotypes: a population-based study on Italian women.

Cortesi L, De Matteis E, Cirilli C, Marcheselli L, Proietto M, Federico M.

Tumori. 2012 Nov;98(6):743-50. doi: 10.1700/1217.13498.

PMID:
23389361
[PubMed - indexed for MEDLINE]
14.

Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.

Lin NU, Vanderplas A, Hughes ME, Theriault RL, Edge SB, Wong YN, Blayney DW, Niland JC, Winer EP, Weeks JC.

Cancer. 2012 Nov 15;118(22):5463-72. doi: 10.1002/cncr.27581. Epub 2012 Apr 27.

PMID:
22544643
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers.

Chen YT, Ross DS, Chiu R, Zhou XK, Chen YY, Lee P, Hoda SA, Simpson AJ, Old LJ, Caballero O, Neville AM.

PLoS One. 2011 Mar 18;6(3):e17876. doi: 10.1371/journal.pone.0017876.

PMID:
21437249
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

HER2 expression in Brazilian patients with estrogen and progesterone receptor-negative breast carcinoma.

Ramalho S, Serra KP, Vassallo J, Soares FA, Pinto GA, Teixeira LC, da Cunha IW, Derchain SF, de Souza G.

Acta Histochem. 2013 Mar;115(2):120-7. doi: 10.1016/j.acthis.2012.05.002. Epub 2012 May 29.

PMID:
22647460
[PubMed - indexed for MEDLINE]
17.

EGFR overexpression relates to triple negative profile and poor prognosis in breast cancer patients in Tunisia.

Kallel I, Khabir A, Boujelbene N, Abdennadher R, Daoud J, Frikha M, Aifa S, Sallemi-Boudawara T, Rebaï A.

J Recept Signal Transduct Res. 2012 Jun;32(3):142-9. doi: 10.3109/10799893.2012.664552. Epub 2012 Mar 6.

PMID:
22394363
[PubMed - indexed for MEDLINE]
18.

Estrogen receptor, progesterone receptor, and Her 2 Neu positivity and its association with tumour characteristics and menopausal status in a breast cancer cohort from northern Pakistan.

Faheem M, Mahmood H, Khurram M, Qasim U, Irfan J.

Ecancermedicalscience. 2012;6:283. doi: 10.3332/ecancer.2012.283. Epub 2012 Dec 11.

PMID:
23304239
[PubMed]
Free PMC Article
19.

Expression of the androgen receptor and its correlation with molecular subtypes in 980 chinese breast cancer patients.

Qi JP, Yang YL, Zhu H, Wang J, Jia Y, Liu N, Song YJ, Zan LK, Zhang X, Zhou M, Gu YH, Liu T, Hicks DG, Tang P.

Breast Cancer (Auckl). 2012;6:1-8. doi: 10.4137/BCBCR.S8323. Epub 2011 Dec 6.

PMID:
22259247
[PubMed]
Free PMC Article
20.

Triple-negative breast cancer types exhibit a distinct poor clinical characteristic in lymph node-negative Chinese patients.

Liu ZB, Liu GY, Yang WT, Di GH, Lu JS, Shen KW, Shen ZZ, Shao ZM, Wu J.

Oncol Rep. 2008 Oct;20(4):987-94.

PMID:
18813844
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk